- Home
- YSXT vs IMUX Comparison
YSXT vs IMUX Comparison
Compare YSXT & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- IMUX
- Stock Information
- Founded
- YSXT 2011
- IMUX 2016
- Country
- YSXT China
- IMUX United States
- Employees
- YSXT N/A
- IMUX N/A
- Industry
- YSXT Automotive Aftermarket
- IMUX Biotechnology: Pharmaceutical Preparations
- Sector
- YSXT Consumer Discretionary
- IMUX Health Care
- Exchange
- YSXT Nasdaq
- IMUX Nasdaq
- Market Cap
- YSXT 79.2M
- IMUX 90.3M
- IPO Year
- YSXT 2024
- IMUX N/A
- Fundamental
- Price
- YSXT $4.52
- IMUX $1.11
- Analyst Decision
- YSXT
- IMUX Strong Buy
- Analyst Count
- YSXT 0
- IMUX 6
- Target Price
- YSXT N/A
- IMUX $13.20
- AVG Volume (30 Days)
- YSXT 52.5K
- IMUX 657.0K
- Earning Date
- YSXT 02-24-2025
- IMUX 05-07-2025
- Dividend Yield
- YSXT N/A
- IMUX N/A
- EPS Growth
- YSXT N/A
- IMUX N/A
- EPS
- YSXT 0.18
- IMUX N/A
- Revenue
- YSXT $66,143,276.00
- IMUX N/A
- Revenue This Year
- YSXT N/A
- IMUX N/A
- Revenue Next Year
- YSXT N/A
- IMUX N/A
- P/E Ratio
- YSXT $27.40
- IMUX N/A
- Revenue Growth
- YSXT 21.23
- IMUX N/A
- 52 Week Low
- YSXT $2.06
- IMUX $0.83
- 52 Week High
- YSXT $6.27
- IMUX $2.11
- Technical
- Relative Strength Index (RSI)
- YSXT N/A
- IMUX 56.34
- Support Level
- YSXT N/A
- IMUX $0.86
- Resistance Level
- YSXT N/A
- IMUX $1.01
- Average True Range (ATR)
- YSXT 0.00
- IMUX 0.09
- MACD
- YSXT 0.00
- IMUX 0.02
- Stochastic Oscillator
- YSXT 0.00
- IMUX 71.67
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.